The Corporate Strategy and Development team at Spyre Therapeutics oversees the strategic planning and execution of business initiatives, including mergers and acquisitions, partnerships, and corporate growth opportunities. They ensure alignment across preclinical and clinical development efforts, operational optimization, and contractual agreements to advance the company's innovative treatments for inflammatory bowel disease.
Andrew Spencer
Svp, Preclinical Research And ...
David Giles
Senior Director, Corporate Str...
Deanna Nguyen
Svp, Clinical Development
Emily Lewis
Director, Corporate Strategy
Joshua Friedman
Svp, Clinical Development
Judy Schmitt
Senior Manager, Contracts And ...
Justin Lafountaine
Svp, Corporate Development
Mira Huyghe
Svp, Development Operations
View all